Loading company…
Stockholm-based biopharmaceutical company developing blood sugar and weight management products using its SiPore technology.
Sigrid Therapeutics uses its patented SiPore technology to make Carb Fence, a medical food for people with prediabetes and diabetes, and Glucose Stabiliser, a daily supplement for long-term metabolic health. Glucose Stabiliser is sold direct to consumers through the company's e-commerce store, while Carb Fence is aimed at healthcare providers and patients with metabolic conditions. Founded in 2014 by Sana Alajmovic and Tore Bengtsson, the company is based in Stockholm, Sweden and is at the Series A stage; it raised USD 5 million in venture funding in January 2026.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in